Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism - From the COMMAND VTE Registry.
暂无分享,去创建一个
M. Toyofuku | Takeshi Kimura | T. Morimoto | H. Shiomi | Takao Kato | H. Mabuchi | T. Tada | Y. Yoshikawa | H. Amano | Po-min Chen | K. Ono | M. Akao | T. Makiyama | Y. Yamashita | T. Izumi | Kitae Kim | S. Saga | J. Sakamoto | T. Takase | S. Hiramori | M. Oi | Yohei Kobayashi | K. Murata | Y. Tsuyuki | T. Sasa | Minako Kinoshita | K. Togi | K. Takabayashi | Jiro Sakamoto | Yusuke Yoshikawa | Maki Oi | Yoshiaki Tsuyuki | Toru Takase
[1] S. Haneuse. Distinguishing Selection Bias and Confounding Bias in Comparative Effectiveness Research , 2016, Medical care.
[2] Takeshi Kimura,et al. Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE Registry. , 2018, Circulation journal : official journal of the Japanese Circulation Society.
[3] E. Oger,et al. Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.
[4] Paolo Prandoni,et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. , 2007, Haematologica.
[5] J. Kline,et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). , 2011, Journal of the American College of Cardiology.
[6] John A. Heit,et al. The epidemiology of venous thromboembolism , 2003, Journal of Thrombosis and Thrombolysis.
[7] G. Moneta,et al. The hemodynamics and diagnosis of venous disease. , 2007, Journal of vascular surgery.
[8] Piotr Pruszczyk,et al. Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism , 2008 .
[9] F. Rosendaal,et al. Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event , 2010, Journal of thrombosis and haemostasis : JTH.
[10] G. Lip,et al. Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism. , 2017, The American journal of cardiology.
[11] M. Prins,et al. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. , 1999, Archives of internal medicine.
[12] A. Ciampi,et al. Men had a higher risk of recurrent venous thromboembolism than women: a large population study. , 2012, Gender medicine.
[13] E. Minar,et al. The risk of recurrent venous thromboembolism in men and women. , 2004, The New England journal of medicine.
[14] P. Ridker,et al. Hormonal factors and risk of recurrent venous thrombosis: the Prevention of Recurrent Venous Thromboembolism trial , 2006, Journal of thrombosis and haemostasis : JTH.
[15] H. Almodaimegh,et al. Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis. , 2013, Thrombosis research.
[16] M. Toyofuku,et al. Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry , 2019, Journal of Thrombosis and Thrombolysis.
[17] Samuel Z Goldhaber,et al. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.
[18] R. White,et al. Racial and gender differences in the incidence of recurrent venous thromboembolism , 2006, Thrombosis and Haemostasis.
[19] B. Lämmle,et al. Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study. , 2017, The American journal of medicine.
[20] F. Rosendaal,et al. Risk assessment for recurrent venous thrombosis , 2010, The Lancet.
[21] Jeroen J. Bax,et al. ESC Guidelines on the diagnosis and management of acute pulmonary embolism , 2014 .
[22] Paolo Prandoni,et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[23] G. Raskob,et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. , 2013, The New England journal of medicine.
[24] G. Moneta. Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism: Findings From the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry , 2009 .
[25] Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[26] J. Kline,et al. Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association , 2011, Circulation.
[27] S. Schulman,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.
[28] M. Monreal,et al. Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism , 2014, Medicine.
[29] T. Baglin,et al. High risk of recurrent venous thromboembolism in men , 2004, Journal of thrombosis and haemostasis : JTH.